APR 11, 2017 12:21 PM PDT

Prostate Cancer has a Diagnostic 'Smell'

WRITTEN BY: Xuan Pham

Can the scent of urine hold molecular clues for the detection of prostate cancer? Inspired by canine companions that can seemingly sniff out certain compounds in the urine of men with prostate cancer, researchers are hoping to develop a machine version of this sniff detector. "If dogs can smell prostate cancer, we should be able to, too," said one of the investigators.

Prostate cancer represents a huge health risk for half the world’s population, as it is the most common form of cancer in men. Current detection methods include the wince-inducing digital rectal exam (DRE) and blood tests that measure prostate-specific antigen (PSA). However, prostate cancer can only be truly confirmed with invasive prostate biopsies.

PSA levels for healthy men are usually less than 4 nanograms per milliliter (ng/mL) of blood. However, having more or less PSA than that range doesn’t guarantee cancer or no cancer, respectively. Furthermore, PSA level cutoffs are not standardized, which contributes to increased cases of false negatives and false positives. This ambiguity often leads to biopsies that increase the risk for complications, as well as psychological and financial stress.

The sniff test would be an important leap forward, with the possibility of replacing traditional invasive diagnostic procedures that are currently in practice. In addition to reducing unnecessary biopsies, the sniff test could provide early detection if prostate cancer is present, which would improve the outcome of the treatment.

Researchers at Indiana University-Purdue University Indianapolis tested the urine samples collected from 100 men undergoing prostate biopsies. They employed a gas chromatography-mass spectrometry (GC-MS) technique to detect volatile organic compounds (VOCs) in the urine. This electronic “nose” identified a set of molecules that seemed to be unique to prostate cancer. In comparing this data to the biopsies, the molecules were present in 90 percent of men who were diagnosed with prostate cancer. By contrast, these molecules were absent from men who were free of cancer.

The sniff test could save men who test negative from undergoing invasive prostate biopsies. Conversely, positive cancer profiles in urine samples would alert doctors and crucial treatments could proceed without delay.

The team hopes to further validate their findings in larger studies with other centers. Interestingly, they are also planning to validate their results against the canine nose - an experiment which may carry big implications for the sensitivity of a dog’s sniffing ability!

Additional sources: MNT

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
JUL 24, 2018
Cancer
JUL 24, 2018
Veterans with Cancer Get Streamlined Access to NCI Clinical Trials
Veterans with cancer, and the VA that cares for them, struggle to navigate the complex world of clinical trials but a collaborative agreement between VA and NCI could fix that....
AUG 14, 2018
Cancer
AUG 14, 2018
Using Arsenic to Enhance Cancer Therapies Beyond Leukemia
An already existing combination of arsenic and all-trans retinoic acid is found to inhibit a key signaling pathway that exerts broad effect on oncogenic processes for some solid tumors....
SEP 15, 2018
Clinical & Molecular DX
SEP 15, 2018
Cancer & Anoikis: A Match Not Made in Heaven
Anoikis have always been intimately entwined with cancer, henceforth the quest to seek how they came to be as such....
NOV 05, 2018
Cell & Molecular Biology
NOV 05, 2018
Using Imaging to Understand Cancer Growth
Most types of cells in our body go through a critical renewal process in which cells divide into two new ones. But it can get out of control as well....
DEC 06, 2018
Drug Discovery
DEC 06, 2018
Repurposing Cancer Drugs For HPV Treatment
Drug repurposing is transforming the health care world. The idea that old, previously-- FDA approved drugs could be altered and to be used again for the tr...
DEC 11, 2018
Cancer
DEC 11, 2018
FDA approves two new drugs for cancers with specific genetic mutations
Last month the FDA approved two new drugs for cancer, both drugs target cancers with specific genetic mutations which made geneticists and oncologists optimistic on the future of cancer thera...
Loading Comments...